184 related articles for article (PubMed ID: 16095762)
1. Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter.
Wenzel B; Sorger D; Heinitz K; Scheunemann M; Schliebs R; Steinbach J; Sabri O
Eur J Med Chem; 2005 Dec; 40(12):1197-205. PubMed ID: 16095762
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site.
Scheunemann M; Sorger D; Wenzel B; Heinitz K; Schliebs R; Klingner M; Sabri O; Steinbach J
Bioorg Med Chem; 2004 Mar; 12(6):1459-65. PubMed ID: 15018919
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
Shiba K; Ogawa K; Ishiwata K; Yajima K; Mori H
Bioorg Med Chem; 2006 Apr; 14(8):2620-6. PubMed ID: 16434200
[TBL] [Abstract][Full Text] [Related]
4. New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure.
Barthel C; Sorger D; Deuther-Conrad W; Scheunemann M; Schweiger S; Jäckel P; Roghani A; Steinbach J; Schüürmann G; Sabri O; Brust P; Wenzel B
Eur J Med Chem; 2015 Jul; 100():50-67. PubMed ID: 26071858
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT).
Kovac M; Mavel S; Deuther-Conrad W; Méheux N; Glöckner J; Wenzel B; Anderluh M; Brust P; Guilloteau D; Emond P
Bioorg Med Chem; 2010 Nov; 18(21):7659-67. PubMed ID: 20889347
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter.
Zea-Ponce Y; Mavel S; Assaad T; Kruse SE; Parsons SM; Emond P; Chalon S; Giboureau N; Kassiou M; Guilloteau D
Bioorg Med Chem; 2005 Feb; 13(3):745-53. PubMed ID: 15653342
[TBL] [Abstract][Full Text] [Related]
7. First CoMFA characterization of vesamicol analogs as ligands for the vesicular acetylcholine transporter.
Szymoszek A; Wenzel B; Scheunemann M; Steinbach J; Schüürmann G
J Med Chem; 2008 Apr; 51(7):2128-36. PubMed ID: 18324757
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT).
Kozaka T; Uno I; Kitamura Y; Miwa D; Ogawa K; Shiba K
Bioorg Med Chem; 2012 Aug; 20(16):4936-41. PubMed ID: 22831799
[TBL] [Abstract][Full Text] [Related]
9. Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter?
Lindemann M; Deuther-Conrad W; Moldovan R; Sekhar KVGC; Brust P; Wenzel B
Bioorg Med Chem; 2017 Oct; 25(19):5107-5113. PubMed ID: 28347632
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
11. N-hydroxyalkyl derivatives of 3 beta-phenyltropane and 1-methylspiro[1H-indoline-3,4'-piperidine]: vesamicol analogues with affinity for monoamine transporters.
Efange SM; Kamath AP; Khare AB; Kung MP; Mach RH; Parsons SM
J Med Chem; 1997 Nov; 40(24):3905-14. PubMed ID: 9397171
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolovesamicols--synthesis, structure and VAChT binding of two 4-fluorobenzoyl regioisomers.
Wenzel B; Li Y; Kraus W; Sorger D; Sabri O; Brust P; Steinbach J
Bioorg Med Chem Lett; 2012 Mar; 22(6):2163-6. PubMed ID: 22365760
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
Kitamura Y; Kozaka T; Miwa D; Uno I; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2016 Feb; 30(2):122-9. PubMed ID: 26608176
[TBL] [Abstract][Full Text] [Related]
14. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
[TBL] [Abstract][Full Text] [Related]
15. Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation.
Efange SM; Khare AB; Mach RH; Parsons SM
J Med Chem; 1999 Jul; 42(15):2862-9. PubMed ID: 10425095
[TBL] [Abstract][Full Text] [Related]
16. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine binding site in the vesicular acetylcholine transporter.
Ojeda AM; Kolmakova NG; Parsons SM
Biochemistry; 2004 Sep; 43(35):11163-74. PubMed ID: 15366926
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter.
Efange SM; Khare AB; von Hohenberg K; Mach RH; Parsons SM; Tu Z
J Med Chem; 2010 Apr; 53(7):2825-35. PubMed ID: 20218624
[TBL] [Abstract][Full Text] [Related]
19. In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.
Ogawa K; Shiba K
Contrast Media Mol Imaging; 2018; 2018():4535476. PubMed ID: 30008624
[TBL] [Abstract][Full Text] [Related]
20. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]